Home/Filings/4/0001493152-23-046151
4//SEC Filing

FR Capital Holdings, L.P. 4

Accession 0001493152-23-046151

CIK 0001603207other

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 5:00 PM ET

Size

8.8 KB

Accession

0001493152-23-046151

Insider Transaction Report

Form 4
Period: 2023-12-21
Transactions
  • Sale

    Ordinary Shares, par value NIS 0.35 each

    2023-12-22$2.41/sh45,000$108,284989,478 total(indirect: See Footnote)
  • Sale

    Ordinary Shares, par value NIS 0.35 each

    2023-12-21$2.51/sh2,867$7,1911,034,478 total(indirect: See Footnote)
Footnotes (3)
  • [F1]FR Capital Holdings, L.P. (the "Reporting Person") is the investment manager to First Round Capital V, LP, a Delaware limited partnership ("FRCV"), and First Round Capital VIII-F, LP, a Delaware limited partnership ("FRCVIIIF"). Josh Kopelman and William Trenchard are the managing members of the Reporting Person. As of December 26, 2023, FRCV held 403,294 ordinary shares, par value NIS 0.35 each ("Ordinary Shares") of Notable Labs, Ltd. and FRCVIIIF held 586,184 Ordinary Shares. The Reporting Person's and Messrs. Kopelman and Trenchard's beneficial ownership is limited to their pecuniary interest, if any, in such securities.
  • [F2]On December 21, 2023, FRCV sold 1,063 Ordinary Shares and FRCVIIIF sold 1,804 Ordinary shares, each at a weighted average price of $2.508 per share. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]On December 22, 2023, FRCV sold 16,657 Ordinary Shares and FRCVIIIF sold 28,343 Ordinary shares, each at a weighted average price of $2.4063 per share. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

Notable Labs, Ltd.

CIK 0001603207

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001776703

Filing Metadata

Form type
4
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 5:00 PM ET
Size
8.8 KB